Go to the list of all blogs
AI dvisor's Avatar
published in Blogs
Nov 06, 2026
TickeronGET DAILY SIGNALS
Why Is Calumet, Inc. (CLMT) Stock Down -8% Today?

Why Is Calumet, Inc. (CLMT) Stock Down -8% Today?

Key Takeaways

  • CLMT fell roughly 8% to about $39.88, down from a prior close of $43.35.
  • The decline came despite a big third-quarter earnings beat, as investors focused on management's warning that the specialty-products windfall is not a sustainable "new normal."
  • Secondary pressures included heavy planned fourth-quarter maintenance downtime and a revised Warburg Pincus agreement that raises a preferred return.
  • The move reflected a "sell the news" reaction rather than a fundamental miss, highlighting valuation and sustainability concerns.
  • Traders are watching specialty-margin normalization, deleveraging progress, and the MaxSAF renewable expansion.
  • For more detail on valuation, results, and the outlook, explore Price Targets, Earnings, and Forecast.
  • Discover the strongest AI-driven trading strategies currently in the market by exploring Trending AI Robots.

Opening Summary

Calumet, Inc. (CLMT) is a specialty hydrocarbon products and renewable fuels producer based in Indianapolis, Indiana. The company manufactures lubricating oils, waxes, solvents, fuels, and sustainable aviation fuel (SAF), operating integrated specialty and renewables businesses. On November 6, 2026, shares traded down approximately 8% to around $39.88, compared with the prior session's closing price of $43.35. The sharp decline came even as Calumet reported third-quarter results that comfortably beat analyst expectations, signaling that investors were focused on forward-looking concerns rather than the headline numbers.

Earnings Beat Met With a "Sell the News" Reaction

The immediate catalyst was Calumet's third-quarter 2026 earnings report. The company posted revenue of about $1.68 billion, up 56.1% year over year and well above consensus, while GAAP earnings per share of $2.91 topped estimates by a wide margin. Adjusted EBITDA of roughly $347 million also exceeded forecasts, driven by record performance in the specialty products and renewables segments.

Despite the strong print, shares moved lower. The reaction reflects a classic "sell the news" dynamic: the stock had already rallied significantly ahead of the report, and the headline beat was widely anticipated. More importantly, management signaled that the exceptional specialty margins were tied to an unusually tight global supply environment that is expected to normalize, rather than a durable structural shift.

Guidance and Sustainability Concerns

A central drag on sentiment was management's own framing of the quarter. Company executives acknowledged that the outsized specialty-products profitability—which drove adjusted gross profit per barrel sharply higher—reflects temporary supply-chain disruptions and a global specialty shortage. The implied message was that this earnings power may not persist once base-oil capacity returns, casting doubt on the sustainability of the current earnings run rate.

Additional headwinds reinforced the cautious tone. The fourth quarter is expected to carry heavy maintenance downtime, including a turnaround at the Shreveport facility and a Montana Renewables tie-in for much of November. These factors point to a sequentially softer quarter ahead, tempering enthusiasm over the record results just reported.

Corporate Announcements and Balance-Sheet Overhang

The move also followed corporate developments announced around the earnings release. Calumet disclosed details of an asset-lease arrangement and a revised agreement with Warburg Pincus that increases a preferred return to 11.5%, adding a layer of cost and complexity for equity holders. Meanwhile, stockholders' equity remains negative, a lingering overhang that can amplify volatility in a down market.

On the positive side, the company has retired more than $265 million of high-cost debt in recent months, reducing interest expense and lowering net leverage. However, these balance-sheet improvements were not enough to offset near-term operational and valuation concerns in today's session.

Market Context and Trading Activity

The decline occurred on elevated volume, reflecting active participation and distribution following the earnings release. The move did not appear to track a broad energy-sector selloff; rather, it was a company-specific reaction to the earnings and guidance narrative. Shares had been strong through 2026, and the pullback suggests investors were taking profits while reassessing how much of the specialty-margin windfall is repeatable. The stock's slide also brought it back toward levels last seen before the recent rally, testing short-term support and moving averages.

What Comes Next for CLMT

Looking ahead, investors will focus on whether specialty margins hold up better than management's cautious guidance implies, and whether fourth-quarter maintenance downtime materially reduces output. Progress on the MaxSAF expansion and the company's deleveraging efforts remain key watch items. Risks include a faster-than-expected normalization of specialty prices, elevated financing costs tied to the revised Warburg Pincus arrangement, and persistent negative equity. Conversely, continued strength in the renewables business and further debt reduction could support sentiment. The balance of analyst commentary remains cautious, underscoring uncertainty about the durability of the recent earnings surge.

Trending AI Robots

Tickeron's Trending AI Robots page showcases a curated selection of the platform's strongest-performing AI trading bots under current market conditions. Tickeron offers hundreds of AI bots covering thousands of tickers, each varying by strategy, timeframe, performance metrics, and traded symbols. The trending section highlights only those bots demonstrating standout results right now, giving traders a quick way to see which automated strategies are adapting best to today's market. Explore the page to see which strategies are currently leading.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CLMT

CLMT in -9.08% downward trend, declining for three consecutive days on November 06, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CLMT declined for three days, in 230 of 298 cases, the price declined further within the following month. The odds of a continued downward trend are 77%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 19, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CLMT as a result. In 55 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 73%.

The Moving Average Convergence Divergence Histogram (MACD) for CLMT turned negative on October 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 31 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.

CLMT moved below its 50-day moving average on October 21, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CLMT crossed bearishly below the 50-day moving average on October 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 67%.

The Aroon Indicator for CLMT entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +3.85% 3-day Advance, the price is estimated to grow further. Considering data from situations where CLMT advanced for three days, in 263 of 326 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

CLMT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-3.064) is normal, around the industry mean (2.365). P/E Ratio (-25.740) is within average values for comparable stocks, (-17.546). Projected Growth (PEG Ratio) (1.070) is also within normal values, averaging (1.548). Dividend Yield (0.069) settles around the average of (0.040) among similar stocks. P/S Ratio (1.100) is also within normal values, averaging (48.960).

The Tickeron Profit vs. Risk Rating rating for this company is 28 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 35 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. CLMT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are DuPont de Nemours (NYSE:DD), Chemours Company (The) (NYSE:CC).

Industry description

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

Market Cap

The average market capitalization across the Chemicals: Specialty Industry is 11.69B. The market cap for tickers in the group ranges from 50 to 237.52B. LIN holds the highest valuation in this group at 237.52B. The lowest valued company is JSCPY at 50.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Specialty Industry was -3%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was -11%. AMTX experienced the highest price growth at 30%, while YMAT experienced the biggest fall at -38%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Specialty Industry was -1%. For the same stocks of the Industry, the average monthly volume growth was 27% and the average quarterly volume growth was -56%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 51
Price Growth Rating: 56
SMR Rating: 78
Profit Risk Rating: 82
Seasonality Score: -6 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a producer of specialty hydrocarbon products

Industry ChemicalsSpecialty

Industry
Industrial Specialties
Address
1060 N Capitol Avenue
Phone
+1 317 328-5660
Employees
1540
Web
https://www.calumet.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Analysts expect Q1 2026 revenue of $1.54 billion, reflecting approximately 74% year-over-year growth. Consensus earnings per share (EPS) forecast stands at $0.28, up over 115% from the prior year.
Analysts expect Q1 2026 revenue of $3.00 billion, up 8% from $2.77 billion in the year-ago quarter. Consensus earnings per share (EPS) estimate stands at $4.31, reflecting steady profitability from the cystic fibrosis (CF) portfolio.
Why Is Calumet, Inc. (CLMT) Stock Down -8% Today?